Pharsight

Empliciti patents expiration

List of large molecules

Patent Number Company Patent Title Patent Expiry Activity Alert
US7709610 NA Therapeutic use of anti-CS1 antibodies
Mar, 2029

(5 years from now)

Ingredients: ELOTUZUMAB

900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight

Join them to stay ahead in capturing the next drug going generic